Merck & Co. Unrecorded Unconditional Purchase Obligation increased by 118.6% to $400.00M in Q4 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates higher future cash commitments, which could impact future liquidity and financial flexibility.
This represents future payment obligations under non-cancelable purchase contracts that are not yet recognized as liabil...
Often disclosed in footnotes; high levels relative to revenue may indicate significant supply chain dependency.
other_unrecorded_unconditional_purchase_obligation_balan_a30cd0| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $183.00M | $400.00M |
| QoQ Change | — | +118.6% |
| YoY Change | — | +118.6% |